Medifast INC Form 4 insider transactions

James P. Maloney, CFO of Medifast, Inc., reported the disposal of common stock to cover withholding tax obligations upon the vesting of restricted stock units.

Jonathan Barrett MacKenzie, VP of Finance & CAO at Medifast, Inc., reported disposing of shares to cover withholding tax obligations upon vesting of restricted stock units.

Daniel Chard, Chairman & CEO of Medifast, Inc., reports disposals of common stock to cover withholding tax obligations upon vesting of restricted stock units.

Medifast's Chief Financial Officer, James P. Maloney, reports the acquisition of 8,718 shares of common stock through a restricted stock unit grant.

Jonathan Barrett MacKenzie, VP, Finance & CAO of Medifast, Inc., acquired 2,565 shares of common stock through a restricted stock unit grant on March 13, 2024.

Medifast CEO Daniel Chard received 45,087 restricted stock units and reported beneficial ownership of Medifast shares, including those held in a family trust.

Director Scott Schlackman exercised stock options and sold shares of Medifast Inc. on March 8, 2024.